Growth Metrics

Lexicon Pharmaceuticals (LXRX) EPS (Basic) (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Lexicon Pharmaceuticals 872.52 Mn 701.87 Mn 20.99 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 93.78%
Dec 31, 2025 0.00%
Sep 30, 2025 -500.00%
Jun 30, 2025 114.29%
Mar 31, 2025 22.22%
Dec 31, 2024 50.00%
Sep 30, 2024 -5.88%
Jun 30, 2024 15.00%
Mar 31, 2024 0.00%
Dec 31, 2023 4.76%
Sep 30, 2023 4.55%
Jun 30, 2023 -29.41%
Mar 31, 2023 0.00%
Dec 31, 2022 -30.77%
Sep 30, 2022 18.75%
Jun 30, 2022 0.00%
Mar 31, 2022 5.88%
Dec 31, 2021 -6.25%
Sep 30, 2021 -23.08%
Jun 30, 2021 13.33%
Mar 31, 2021 -400.00%
Dec 31, 2020 -103.90%
Sep 30, 2020 218.46%
Jun 30, 2020 -3.17%
Mar 31, 2020 -31.25%
Dec 31, 2019 -122.54%
Sep 30, 2019 1,068.18%
Jun 30, 2019 -4.76%
Mar 31, 2019 -31.25%
Dec 31, 2018 38.46%
Sep 30, 2018 21.21%
Jun 30, 2018 17.50%
Mar 31, 2018 -60.00%
Dec 31, 2017 10.71%
Sep 30, 2017 15.15%
Jun 30, 2017 -6.45%
Mar 31, 2017 0.00%
Dec 31, 2016 11.43%
Sep 30, 2016 5.41%
Jun 30, 2016 -8.82%
Mar 31, 2016 -140.48%
Dec 31, 2015 347.06%
Sep 30, 2015 -25.93%
Jun 30, 2015 0.00%
Mar 31, 2015 -800.00%
Dec 31, 2014 94.55%
Sep 30, 2014 -57.14%
Jun 30, 2014 16.67%
Mar 31, 2014 -1,300.00%
Dec 31, 2013 50.00%
Sep 30, 2013 0.00%
Jun 30, 2013 -20.00%
Mar 31, 2013 0.00%
Dec 31, 2012 16.67%
Sep 30, 2012 -20.00%
Jun 30, 2012 16.67%
Mar 31, 2012 40.00%
Dec 31, 2011 -25.00%
Sep 30, 2011 0.00%
Jun 30, 2011 11.11%
Mar 31, 2011 -28.57%
Dec 31, 2010 12.50%
Sep 30, 2010 -14.29%